November 1, 2016 / 11:57 AM / a year ago

BUZZ-Valeant Pharmaceuticals: Eases after falling on criminal probe reports

** Canadian drugmaker’s U.S.-listed shares up about 4 pct at $18.55 premarket after closing down 12.3 pct on Monday

** Valeant’s former CEO and CFO are at the center of a U.S. criminal probe over the co’s ties to a specialty pharmacy that helped boost its sales, Bloomberg reported

** Co noted that a year ago it disclosed it was under investigation by U.S. prosecutors

** The latest headlines on criminal charges appear to be related to progress on an investigation that was disclosed by the WSJ in August - Mizuho Securities USA Inc

** Valeant’s Toronto-listed stock closed down 12 pct at C$23.94

** Up to Monday’s close, VRX’s U.S. stock had fallen 82.5 pct YTD

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below